InvestorsHub Logo
Followers 6
Posts 877
Boards Moderated 0
Alias Born 09/28/2012

Re: stockrafter post# 8685

Friday, 06/14/2024 6:01:52 PM

Friday, June 14, 2024 6:01:52 PM

Post# of 8750
Interesting. I wonder when this and Alteogen's will get approved. It's certainly odd that they have been able to develop a "standalone" before Halo's patents expire. In any case, this is one of the reasons Halo should not rely just on Enhanze and get serious on M&A imo.

"HLB3-002 is a standalone of Halozyme's rHuPH20 (Original) and has the same amino acid sequence."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News